Tower Research Capital LLC (Trc) Acer Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.57 - $1.28 $6,653 - $14,940	-11,672 Reduced 91.77%	1,047 $0
Q2 2023 Aug 14, 2023	BUY	$0.75 - $1.14 $8,856 - $13,462	11,809 Added 1297.69%	12,719 $11,000
Q1 2023 May 09, 2023	SELL	$0.67 - $3.05 $165 - $753	-247 Reduced 21.35%	910 $1,000
Q4 2022 Feb 10, 2023	SELL	$1.13 - $4.15 $5,576 - $20,480	-4,935 Reduced 81.01%	1,157 $3,000
Q3 2022 Nov 10, 2022	BUY	$1.28 - $1.6 $4,646 - $5,808	3,630 Added 147.44%	6,092 $8,000
Q2 2022 Aug 15, 2022	BUY	$1.19 - $3.04 $1,980 - $5,058	1,664 Added 208.52%	2,462 $3,000
Q1 2022 May 12, 2022	SELL	$1.98 - $2.98 $861 - $1,296	-435 Reduced 35.28%	798 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.88 - $2.9 $2,318 - $3,575	1,233 New	1,233 $3,000
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.86 $4,834 - $6,011	-2,102 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.52 - $3.18 $4,631 - $5,844	1,838 Added 696.21%	2,102 $6,000
Q1 2021 May 17, 2021	SELL	$2.47 - $4.39 $1,570 - $2,792	-636 Reduced 70.67%	264 $1,000
Q4 2020 Feb 16, 2021	BUY	$2.34 - $2.99 $2,106 - $2,691	900 New	900 $2,000
Q2 2020 Aug 13, 2020	SELL	$1.53 - $4.53 $1,875 - $5,553	-1,226 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.18 - $5.86 $189 - $943	161 Added 15.12%	1,226 $2,000
Q4 2019 Feb 07, 2020	BUY	$2.85 - $4.2 $3,035 - $4,473	1,065 New	1,065 $4,000
Q3 2019 Nov 05, 2019	SELL	$1.95 - $3.93 $4,293 - $8,653	-2,202 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.45 - $26.86 $7,596 - $59,145	2,202 New	2,202 $8,000
Q1 2019 May 14, 2019	SELL	$20.4 - $25.15 $5,426 - $6,689	-266 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$16.55 - $30.22 $11,651 - $21,274	-704 Reduced 72.58%	266 $5,000
Q3 2018 Nov 13, 2018	BUY	$18.0 - $32.83 $17,460 - $31,845	970 New	970 $30,000

Others Institutions Holding ACER

# of Institutions

Shares Held

365

Call Options Held

Put Options Held

Burleson & Company, LLC

365
Shares

$0
0.0% of portfolio

View Full List

About Acer Therapeutics Inc.

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

More about ACER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account